E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Docs on Twitter


About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.

  • Law Blogs

Become a Fan

« Eli Lilly & Co. v. Actavis Elizabeth LLC (Fed. Cir. 2011) | Main | Forum on European Pharmaceutical Regulatory Law »

August 11, 2011

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d83451ca1469e2015390a09089970b

Listed below are links to weblogs that reference House Legislators Lobby to Exclude 12-Year Data Exclusivity Period from Free Trade Agreement:

Comments

Don,

Frankly, Waxman and his liberal cohorts need to "get a life" and some semblance of "reality" when it comes to biosimilars. Just like the rest of the world needs to realize there's no "free lunch" (aka by imposing price controls on drugs) when it comes to drug development.

The comments to this entry are closed.

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30